Instituto Nacional De Cancerologia De Mexico
Clinical trials sponsored by Instituto Nacional De Cancerologia De Mexico, explained in plain language.
-
Probiotic-Diet combo aims to stop cancer pill side effect
Prevention Recruiting nowThis study tests whether adding glutamine and a probiotic (Lactobacillus reuteri) to a bland diet can prevent diarrhea caused by targeted therapy pills (TKIs) in people with advanced non-small cell lung cancer. About 28 participants will either get the special supplement plus die…
Phase: PHASE3 • Sponsor: Instituto Nacional de Cancerologia de Mexico • Aim: Prevention
Last updated May 02, 2026 00:44 UTC
-
Lung cancer patients may benefit from pulmonary rehab
Symptom relief Recruiting nowThis study is testing whether a pulmonary rehabilitation program can help people with advanced non-small-cell lung cancer preserve muscle mass, improve lung function, and reduce inflammation. About 94 participants will take part in the program while receiving standard cancer trea…
Phase: NA • Sponsor: Instituto Nacional de Cancerologia de Mexico • Aim: Symptom relief
Last updated May 01, 2026 15:57 UTC
-
Muscle mass may predict chemo toxicity in lung cancer patients
Knowledge-focused Recruiting nowThis study is looking at how a person's body composition, especially their fat-free mass (muscle), affects the side effects of chemotherapy in people with advanced non-small cell lung cancer. The goal is to see if adjusting the chemo dose based on muscle mass can reduce toxicity.…
Sponsor: Instituto Nacional de Cancerologia de Mexico • Aim: Knowledge-focused
Last updated May 01, 2026 16:00 UTC